Clinical Trial Update: Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

ClinicalTrials.gov reports completion of a Phase II trial evaluating a combined modality treatment for primary central nervous system lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Lymphoma, B Cell | Phase 2 | Status: COMPLETED